The South African market for hormones in dosage, excluding contraceptives and antibiotics, witnessed a decline from 2013 to 2023, with the market size standing at $157.66 million by 2023. The decline was characterized by fluctuations, including a notable drop in 2022. Year-on-year variations showed modest changes, with the most significant dip in 2022 and a minor decrease in 2023. The five-year CAGR reveals a negative trend, averaging a decrease of 1.09% annually.
Future trends to watch include potential developments in biotechnology and personalized medicine, which might influence demand and innovation within the hormone therapy sector.
